These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1907555)

  • 1. Suppression of proliferation of human epidermal keratinocytes by 1,25-dihydroxyvitamin D3. Analysis of its effect on psoriatic lesion and of its mechanism using human keratinocytes in culture.
    Kitano Y; Ikeda N; Okano M
    Eur J Clin Invest; 1991 Feb; 21(1):53-8. PubMed ID: 1907555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3.
    Chen TC; Holick MF
    Br J Dermatol; 2000 Jul; 143(1):72-8. PubMed ID: 10886138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal and psoriatic keratinocytes.
    Hashimoto K; Matsumoto K; Higashiyama M; Nishida Y; Yoshikawa K
    Br J Dermatol; 1990 Jul; 123(1):93-8. PubMed ID: 2390499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical treatment of psoriatic plaques with 1 alpha, 24 dihydroxyvitamin D3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation.
    Glade CP; van Erp PE; van Hooijdonk CA; Elbers ME; van de Kerkhof PC
    Acta Derm Venereol; 1995 Sep; 75(5):381-5. PubMed ID: 8615058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical calcitriol (1,25-dihydroxyvitamin D3) treatment of psoriasis: an immunohistological evaluation.
    Reichrath J; Perez A; Müller SM; Chen TC; Kerber A; Bahmer FA; Holick MF
    Acta Derm Venereol; 1997 Jul; 77(4):268-72. PubMed ID: 9228216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin.
    Reichrath J; Müller SM; Kerber A; Baum HP; Bahmer FA
    J Am Acad Dermatol; 1997 Jan; 36(1):19-28. PubMed ID: 8996256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin.
    Abe J; Kondo S; Nishii Y; Kuroki T
    J Clin Endocrinol Metab; 1989 Apr; 68(4):851-4. PubMed ID: 2921314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes.
    Matsumoto K; Hashimoto K; Kiyoki M; Yamamoto M; Yoshikawa K
    J Dermatol; 1990 Feb; 17(2):97-103. PubMed ID: 2158504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGF receptor expression and growth of psoriatic and normal human keratinocytes are modulated by 1.25 (OH)2-vitamin D3 ex vivo.
    Boisseau-Garsaud AM; Donatien P; Margerin C; Taïeb A
    Arch Dermatol Res; 1996 Jul; 288(8):453-7. PubMed ID: 8844124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis and vitamin D3. A review of our experience.
    Morimoto S; Yoshikawa K
    Arch Dermatol; 1989 Feb; 125(2):231-4. PubMed ID: 2536537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation versus inhibition of keratinocyte growth by 1,25-Dihydroxyvitamin D3: dependence on cell culture conditions.
    Gniadecki R
    J Invest Dermatol; 1996 Mar; 106(3):510-6. PubMed ID: 8648185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcipotriol inhibits the proliferation of hyperproliferative CD29 positive keratinocytes in psoriatic epidermis in the absence of an effect on the function and number of antigen-presenting cells.
    Jensen AM; Lladó MB; Skov L; Hansen ER; Larsen JK; Baadsgaard O
    Br J Dermatol; 1998 Dec; 139(6):984-91. PubMed ID: 9990360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3.
    MacLaughlin JA; Gange W; Taylor D; Smith E; Holick MF
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5409-12. PubMed ID: 2991921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical treatment of psoriatic plaques with 1,25-dihydroxyvitamin D3: a cell biological study.
    Gerritsen MJ; Rulo HF; Van Vlijmen-Willems I; Van Erp PE; van de Kerkhof PC
    Br J Dermatol; 1993 Jun; 128(6):666-73. PubMed ID: 8101716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Sunitinib ointment alleviates Psoriasis-like inflammation by inhibiting the proliferation and apoptosis of keratinocytes.
    Kuang YH; Lu Y; Liu YK; Liao LQ; Zhou XC; Qin QS; Jia XK; Wu LS; Zhu W; Chen X
    Eur J Pharmacol; 2018 Apr; 824():57-63. PubMed ID: 29382533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1 alpha,24R-dihydroxyvitamin D3 has an ability comparable to that of 1 alpha,25-dihydroxyvitamin D3 to induce keratinocyte differentiation.
    Kobayashi T; Okumura H; Azuma Y; Kiyoki M; Matsumoto K; Hashimoto K; Yoshikawa K
    J Dermatol; 1990 Nov; 17(11):707-9. PubMed ID: 2094749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of epidermal differentiation, tissue inflammation, and T-lymphocyte infilitration in psoriatic plaques by topical calcitriol.
    Lu I; Gilleaudeau P; McLane JA; Heftler N; Kamber M; Gottlieb S; Krueger JG; Gottlieb AB
    J Cutan Pathol; 1996 Oct; 23(5):419-30. PubMed ID: 8915850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of human keratinocytes by a new vitamin D3 analogue in vitro.
    Kobayashi T; Hashimoto K; Yoshikawa K
    J Dermatol Sci; 1998 Jan; 16(2):158-64. PubMed ID: 9459129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D3 and a new analogue, 22-oxacalcitriol, modulate proliferation and interleukin-8 secretion of normal human keratinocytes.
    Koizumi H; Kaplan A; Shimizu T; Ohkawara A
    J Dermatol Sci; 1997 Sep; 15(3):207-13. PubMed ID: 9302649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium.
    Itin PH; Pittelkow MR; Kumar R
    Endocrinology; 1994 Nov; 135(5):1793-8. PubMed ID: 7956903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.